Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology
DOI: 10.1007/s00280-016-3013-y
Links
Tools
A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer
Journal article published in 2016 by
Hiromi Kataoka,
Yoshinori Mori 
,
Takaya Shimura ,
Hirotada Nishie,
Makoto Natsume,
Hisato Mochizuki,
Yoshikazu Hirata,
Satoshi Sobue,
Takashi Mizushima,
Hitoshi Sano,
Yusuke Mizuno,
Makoto Nakamura,
Atsuyuki Hirano,
Kenji Tsuchida,
Kazunori Adachi
and other authors.
,
Takaya Shimura ,
Hirotada Nishie,
Makoto Natsume,
Hisato Mochizuki,
Yoshikazu Hirata,
Satoshi Sobue,
Takashi Mizushima,
Hitoshi Sano,
Yusuke Mizuno,
Makoto Nakamura,
Atsuyuki Hirano,
Kenji Tsuchida,
Kazunori Adachi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 